Management of patients with autoimmune liver disease during COVID-19 pandemic

J Hepatol. 2020 Aug;73(2):453-455. doi: 10.1016/j.jhep.2020.04.002. Epub 2020 Apr 10.

¹ Division of Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Electronic address: ana.lleo@humanitas.it.
² European Reference Network on Hepatological Diseases (ERN RARE-LIVER); Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
³ European Reference Network on Hepatological Diseases (ERN RARE-LIVER); Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁴ Division of Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER).

No abstract available

Publication types